Login or sign up
For business

Errant Gene Therapeutics

4.1· 7 reviews
Average ratingGreat
4.1/ 5

Based on 7 reviews

543%
429%
329%
20%
10%
Ask AI

Ask Trustburn about Errant Gene Therapeutics

Based on 7 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Meg Ciarallo
Reviews 1

I had a great experience with Errant Gene Therapeutics. The company's website is easy to navigate and provides all the necessary information about their services. The team was very professional and knowledgeable, and they answered all my questions promptly. I am impressed with the quality of their work and the efficiency of their process. I would highly recommend Errant Gene Therapeutics to anyone in need of gene therapy solutions.

Jason Corr
Reviews 1

Errant Gene Therapeutics impressed me with their professional approach and high-quality services. The website is user-friendly and provides detailed information about their gene therapy solutions. The team was responsive and knowledgeable, addressing all my concerns. I had a great experience overall and would highly recommend them to others.

Shruti Upadhyaya
Reviews 1

I recently used a gene therapy service and had a positive experience. The company's website was informative and user-friendly. The team was professional and provided excellent customer support. I would recommend their services to anyone in need of gene therapy solutions.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Errant Gene Therapeutics

Errant Gene Therapeutics is a privately held biopharmaceutical company established in 2003. The company’s mission is the development of treatments for life-threatening diseases with a special focus on rare diseases, commonly referred to as “orphan diseases.” EGT is developing its portfolio of pharmaceutical products to correct the erroneous gene expression associated with many of these diseases. EGT therapies are currently being developed for hemoglobinopathies and selected cancers.

Address
218 N Jefferson St Ste 300